Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19--Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions--VISION Network, September 2022-April 2023

Authors :: Link-Gelles, Ruth
Weber, Zachary A.
Reese, Sarah E.
Payne, Amanda B.
Gaglani, Manjusha
Adams, Katherine
Kharbanda, Anupam B.
Natarajan, Karthik
DeSilva, Malini B.
Dascomb, Kristin
Irving, Stephanie A.
Klein, Nicola P.
Grannis, Shaun J.
Ong, Toan C.
Embi, Peter J.
Dunne, Margaret M.
Dickerson, Monica
McEvoy, Charlene
Arndorfer, Julie
Naleway, Allison L.
Goddard, Kristin
Dixon, Brian E.
Griggs, Eric P.
Hansen, John
Valvi, Nimish
Najdowski, Morgan
Timbol, Julius
Rogerson, Colin
Fireman, Bruce
Fadel, William F.
Patel, Palak
Ray, Caitlin S.
Wiegand, Ryan
Ball, Sarah
Tenforde, Mark W.
Source :: Morbidity and Mortality Weekly Report. May 26, 2023, Vol. 72 Issue 21, p579, 10 p.
Publication Year :: 2023
Abstract: On September 1, 2022, CDC's Advisory Committee on Immunization Practices (ACIP) recommended a single bivalent mRNA COVID-19 booster dose for persons aged [greater than or equal to] 12 years who [...]

Subjects :: Medical research
Medicine, Experimental
Messenger RNA
Emergency medicine
Adults
Vaccines
Health

Tools